Mixed Liver Injury: Definition, Classification, and Clinical Implications

Definition & Classification

Mixed liver injury is identified by simultaneous elevation of hepatocellular enzymes (ALT) and cholestatic markers (alkaline phosphatase) with an R value between 2 and 5, where R = (ALT/ULN) ÷ (ALP/ULN)【1】.
The R‑value system classifies liver injury patterns as follows:
- R ≥ 5 – hepatocellular injury (predominant ALT rise)【1】.
- R ≤ 2 – cholestatic injury (predominant ALP rise)【1】.
- R > 2 and < 5 – mixed hepatocellular‑cholestatic injury【1】.
This classification framework was established by the Council of International Organizations of Medical Sciences (CIOMS) in 1990 and remains the international standard for differentiating liver injury patterns【1】.

The R value is calculated as (ALT ÷ ALT‑ULN) ÷ (ALP ÷ ALP‑ULN)【2】.
In individuals with pre‑existing liver disease, the mean baseline ALT and ALP values obtained before drug exposure should replace the laboratory‑provided ULN when computing the R value【1】.
The R value must be determined at the peak of the acute liver injury episode to reflect the maximal enzyme perturbation【1】.
Variability in upper‑limit‑of‑normal (ULN) values for ALP across laboratories, and by sex/age, can influence the R‑value calculation and should be accounted for【1】【3】.

Identification of a mixed pattern narrows the differential diagnosis, prompting consideration of drug‑induced liver injury (DILI), autoimmune hepatitis, and certain viral hepatitis etiologies【2】.
A mixed pattern directs a comprehensive diagnostic work‑up that includes evaluation for hepatocellular causes (e.g., viral hepatitis, autoimmune hepatitis, ischemic hepatopathy) and cholestatic causes (e.g., biliary obstruction, infiltrative disease)【2】.
In suspected DILI cases, the presence of a mixed pattern supports causality assessment and characterizes the phenotypic injury associated with specific drugs【2】.

Compared with pure hepatocellular injury, cholestatic and mixed injury patterns are generally associated with more favorable outcomes following drug withdrawal【4】.

In patients already affected by cholestatic liver disease, mixed or cholestatic DILI may be clinically and histologically indistinguishable from progression of the underlying disease, necessitating careful interpretation【1】【3】.

The American Association for the Study of Liver Diseases defines acute liver injury by any of the following criteria: 1) Alanine aminotransferase (ALT) level ≥5x upper limit of normal (ULN), 2) Alkaline phosphatase (ALP) level ≥2 ULN, or 3) ALT level ≥3 ULN with simultaneous total bilirubin level >2 ULN 5, 6
The European Association for the Study of the Liver recommends that for patients with abnormal baseline liver tests, the ULN should be replaced by the mean baseline values obtained prior to exposure to the suspect agent, and increases should be proportionate to this modified baseline 5

The R value, defined as (ALT/ULN)/(ALP/ULN), can be used to classify acute liver injury into hepatocellular, cholestatic, or mixed patterns, with R ≥5 indicating a hepatocellular pattern, R ≤2 indicating a cholestatic pattern, and R value >2 and <5 indicating a mixed pattern 5

Acute liver injury may present with various histological patterns, including hepatocellular necrosis, cholestatic/mixed injury, microvesicular steatosis, and toxicant-associated steatohepatitis (TASH) 7, 8

The severity of acute liver injury can be graded as follows: Grade 1: Elevated ALT/ALP meeting criteria for liver injury but bilirubin <2 ULN, Grade 2: Elevated ALT/ALP meeting criteria for liver injury and bilirubin ≥2 ULN, or symptomatic hepatitis, Grade 3: Elevated ALT/ALP meeting criteria for liver injury, bilirubin ≥2 ULN, and one of the following: INR ≥1.5, ascites and/or encephalopathy, or other organ failure due to liver injury, Grade 4: Death or transplantation due to liver injury 8, 9

Isolated increases in GGT activity are not markers of cellular damage but rather indicate enzyme induction, and the values used for classification should be those available when liver injury is first recognized 5
Due to differences in clearance kinetics of ALT and ALP, the injury pattern may shift to a cholestatic/mixed signature over time, and in occupational liver diseases, the standard classification used for idiosyncratic drug-induced acute liver failure may not apply due to the direct, massive, and rapid liver damage induced by chemicals 5, 7